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Human kidney displays the class II MHC antigens on tissue dendritic cells
(DC)' and on vascular endothelial cells (1-4) . In addition, variable amounts of
class II antigens are present in the cytoplasm of proximal tubular cells (4) . Rat
kidney is different. In addition to being present on the DC, large amounts of
intracellular class II antigen are seen inside proximal tubular cells ; on the other
hand, very few kidney vascular endothelial cells express class II antigens, and in
those that do, the level of expression is low (5-8) . Human and rat heart and liver
are similar . Thus in both organs in both species the level of class II expression
on endothelial cells is low and the major class II antigen-expressing cells are the
DC . In addition, in the liver, (some of) the Kupffer cells (tissue macrophages)
are strongly class II-positive . The remaining parenchymal structures in the
above three organs do not express detectable amounts of class II (9-11) .
Herein, we show that the level of class II antigen expression in rat organs is
not stable, but may be modulated by exogenous administration of drugs . rIFN-
y and steroids have antagonistic effects on class II antigen presentation in two
separate antigenic compartments : on the presentation of the antigen by the graft
parenchymal (endothelial) cells, and on the number of highly antigenic DC in
tissue .
Materials and Methods
Rats .
￿
The nucleus of the inbred DA (AgB-4 ; RT I') strain was obtained from Professor
J . Gowans, Dunn School of Pathology, Oxford, United Kingdom. Male rats weighing
^-200 g were used for the experiments .
Reagents .
￿
MouseIgGmAbagainst rat class II MHC antigens, MAS 029 (monomorphic,
reactive to all class II molecules) was purchased from Sera-Lab, Ltd., Crawley Down,
Sussex, United Kingdom . FITC-coupled goat anti-mouse IgG and tetramethylrhodamme
isothiocyanate (TRITC)-coupled goat anti-rabbit IgG were obtained from Cappel Labo-
ratories, Cochranville, PA . Rabbit antiserum to factor VIII-related antigen(s) (FVIII-
RAg) was obtained from Dako Immunoglobulins a/s, Copenhagen, Denmark .
rIFN-y was produced in the laboratory of H. Schellekens as follows . The protein was
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' Abbreviations used in this paper:
￿
DC, dendritic cell ; FVIII-RAg, factor VIII-related antigens ;
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prepared from cultures of a transformed Chinese hamster ovary (CHO) cell line carrying
the gene encoding rat IFN-y. The methods of production and partial purification have
been described previously (12). The preparation had sp act of -2-4 X 107 U/mg protein.
Methylprednisolone (MP) (Solu-Medrol) was purchased from Upjohn, Kalamazoo, MI,
and dissolved in PBS before administration.
Double Indirect Immunofuorescence.
￿
Tissues were embedded in Tissue Tek II (Miles
Laboratories Inc., Naperville, IL), frozen in liquid nitrogen and cut using a ReichertJung
microtome (Frigocut Model 2.700; R. Jung Gmbh, Nussloch, Federal Republic of Ger-
many) at -15 °C. For double indirect immunofluorescence, 5-Am frozen sections were
dried in air, fixed for 10 min in acetone at room temperature, and double stained as
follows: sections were exposed for 30 min at room temperature in a humidifiedatmosphere
to a mixture of MAS029 antibody and rabbit anti-FVIII-RAg, they were then washed
three times in PBS before being exposed to a mixture of FITC-coupled goat anti-mouse
Ig and TRITC-coupled goat anti-rabbit Ig. After three washes in PBS, the slides were
air dried and mounted in Aquamount (BDH Chemicals, Ltd., Poole, United Kingdom).
Upon examination of the specimens in a Zeiss Universal Microscope equipped with an
epi-illuminator IIIRS and filters for FITC and TRITC fluorescence, the strongly class
II-positive DC were easily distinguished from the class II-positive vascular endothelial
cells also expressing the FVIII-RAg, and vice versa.
Cells were counted at X400 using a mesh (area, 55,225 Am'). 10-20 fields were
included in the analysis from each area. In the liver, counting started either from the
portal vein or from the central vein. In this study the liver portal area was defined as
being in the immediate vicinity of the portal vein, hepatic artery, and bile duct, to the
extent of periportal connective tissue; the remaining part of the liver was called the
hepatocellular or central vein area and is referred to herein as the central vein area.
As no unequivocally accepted marker antibody for rat DC exists at present, DC were
defined as highly class II-reactive, nonphagocytic, nonparenchymal cells with dendritic
morphology and not expressing FVIII-RAg (9, 13). To visualize phagocytic cells, the
recipient rats were injected with 20% India ink in 0 .5 ml of PBS 2 h before extermination
(9). Phagocytic cells were easily identified by the ingested ink particles. The vascular
(capillary) endothelial cells, which overlapped with DC especially in the renal intertubular
space (7, 9, 13), were recognized by their expression of the FVIII-RAg (13).
Results
3 d after a single i.p. injection of rIFN-y into a DA rat, the number of Ia+
FVIII-RAg DC increased in heart tissue 3.6-fold, from 23 .5 cells/mm2 to 85.1
cells/mm2, while the number of la', FVIII-RAg+ capillary endothelial cells
increased 6.5-fold, from 3 .6 cells/mm2 to 23.5 cells/mm2 (Fig. 1). On day 7 after
injection, the class II expression had decreased back to the original level. In rat
kidney the response was similar though less pronounced in intensity. In rat liver,
the response of the DC to IFN-y was even smaller (not shown); on the other
hand, the response of liver endothelial cells to IFN-y, in particular in the central
vein area, was far more pronounced than in either heart or kidney, with an
increase of la', ink-, FVIII-RAg+ capillary endothelial cells from 5 .4 cells/mm2
to 126.7 cells/mm2 (Fig. 1) .
After injection of IFN-y, the number of liver la- phagocytic cells, most of
which were present in the central vein area, decreased, and the number of Ia+
phagocytic cells increased, indicating an in situ activation of Kupffer cells (not
shown).
Administration of a single bolus of 300 mg/kg of MP together with 105 U/kg
of IFN-y entirely abolished the effects of IFN-y on endothelial cells and DC in
all three organs (Fig. 1).1472
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FIGURE 1.
￿
Effect of 105 U/kg of rIFN-?' (open symbols) on class II expression in capillary
endothelial cells (A) andon the density of tissue DC (B)in rat heart (circles), kidney (triangles),
and liver (squares). The impact of concomitantlyadministered bolus of 300 mg/kg MP (filled
symbols) is also shown. Note logarithmic scale.
The antagonistic effects of steroids on class II expression by endothelial cells
and on the density of tissue DC were investigated further by using different
doses of MP and different schedules of administration (Tables I and II).
A single bolus administration of MP was rather inefficient: 300 mg/kg of MP
was needed to reduce the baseline expression of class I antigens on the endothelial
cells by 30% and the baseline density of DC by 60-70%, whereas 30 mg/kg had
no effect either on baseline or on IFN-y-induced class II expression in rat heart
and kidney (Fig. 1 and Table I). The liver DC and endothelial cells were even
more resistant in both respects (Fig. 1, Table II).
On the other hand, repeated small doses were highly efficient. The baseline
expression of class II on the capillary endothelial cells and the density of tissue
DC were reduced in rat heart and kidney down to a dose range of 1-3 mg/kg/d,
the kidney cells being somewhat more resistant than the heart cells. In the liver,
the baseline class II expression of capillary endothelial cells was practically
abolished at a dose of 1 mg/kg/d; the liver DC were more resistant to steroids
than were the DC in the kidney and heart. A complete inhibition of IFN-y
induced class II expression on the endothelial cells, and an abolishment of IFN-
y-induced increase in DC density was obtained by 1 mg/kg/d of MP in all three
sites of assay.
Discussion
The DC in this study were defined as strongly class II-positive nonphagocytic
cells, which did not display the FVIII-RAg characteristic to the vascular endo-TABLE I
Impact ofIFN--y and/or MP on Expression ofClass II Antigen in DA
Rat Heart and Kidney on Day 3 after Drug Administration
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* The rats received 0.5 ml of 20% India ink in PBS 2 h before killing.
The tissues were processed forfrozen sectionhistology andstained with
mAbdetectingthe classII backbone,MAS029,usingthedouble indirect
immunofluorescence method with rabbit anti-FVIII-RAg (18). EC, en-
dothelial cells.
$The most effective dose of rIFN-y 105 U/kg, was pretested using a
logarithmic scale from 10' U/kg upwards. The lowest dose giving a
maximal response was selected.
§ MP wasgiven at the indicated dose either together with rIFN-'r on day
0 (X 1) or on days 0, 1, and 2 (X 3) after rIFN-y injection. All drugs
were given i .p.
thelial cells. Tubular cells expressing class 11 antigens were easily distinguishable
on morphological grounds. The remaining parenchymal structures in these
organs didnot express any detectable amounts ofclass11(9-11), and thepresence
of lymphoid T or B cells in tissue was excluded by proper antibodies. The
Drug Dose
Number of la-expressingcells/mm'*
DC la`, ink-, Capillary EC la',
FVIII- ink-, FVIII*
Heart Kidney Heart Kidney
None - 40.7 57.9 8.1 9.0
rIFN-y$ 105 U/kg 55.2 74.2 21 .7 21 .7
rIFN-y 105 U/kg 46.2 65.2 7.2 12.6
MP§ 30 mg/kg X 1
rIFN-y 105 U/kg 8.1 21 .7 0.9 1.8
MP 30 mg/kg X 3
rIFN-y 105 U/kg 19.9 36.2 3.6 5.4
MP 10 mg/kg X 3
rIFN-y 105 U/kg 34.4 48.9 5.4 7.2
MP 3 mg/kg X 3
rIFN-y 105 U/kg 37.1 54.3 5.4 7.2
MP 1 mg/kg X 3
MP 300 mg/kg X 1 14.5 23.5 5.4 5.4
MP 30 mg/kg X 1 41 .6 57.9 6.3 10.9
MP 30 mg/kg X 3 10.0 19.9 0.9 3.6
MP 10 mg/kg X 3 19.0 30.8 2.7 3.6
MP 3 mg/kg X 3 24.4 39.8 1.8 7.2
MP 1 mg/kg X 3 30.8 47.1 5.4 9.01474
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localization and appearance ofthe DC in tissue and their properties (i.e., lack of
phagocytosis) are the same as those reported previously by Hart and Fabre (7,
9), who also demonstrated their cell surface and histochemical phenotype and
their bone marrow origin. We consider it likely, therefore, that most of the cells
defined as dendritic cells in this study are indeed dendritic cells.
The tissue macrophages, on the other hand, were defined by their phagocytic
ability and by their ingestion of intravenously administered India ink. As the
possibility remains that India ink did not reach all phagocytic cells, the number
of tissue macrophages (and Kupffer cells) may be slightly underestimated and
that of the DC slightly overestimated. However, those cells that did ingest India
ink may definitely be considered tissue phagocytes.
It hasbeen demonstrated previously by others (14-19) that IFN administration
in vitro upregulates class 11 expression on, e.g., human umbilical cord endothelial
cells and in many cell lines ofnonendothelial origin (14-16). The present in vivo
results confirm the earlier in vitro findings by demonstrating that recombinant
rat IFN-y induces the expression ofclass 11 antigens on the (capillary) endothelial
cells ofrat heart, kidney, and liver. In addition, our results show that the number
of la', FVIII-RAg DC in rat tissue increases in response to IFN-y. Both
responses are abolished by administration of glucocorticosteroids.
Two modes of steroid administration were used: a single bolus administration
on day 0, mimicking the pretreatment of the graft donor to reduce allograft
immunogenicity, and repeated administration of small doses, mimicking the
treatment ofallograft rejection. Using single-bolus administration, ^-300 mg/kg
was required to reduce the density ofDC and class 11 expression in the endothelial
cells in rat heart and kidney. This dose is in the same dose range as the minimal
dose of MP previously reported (20) to be effective in donor pretreatment in the
rat. The liver DC were more resistant. On the other hand, repeated small doses
were highly efficient: a distinct effect was obtained both on baseline and on IFN-
y-induced class II expression on the endothelial cells and on the density oftissue
DC at a dose of 1-3 mg/kg/d. This dose is less than one-tenth the dose of MP
used in most centers for the treatment ofacute allograft rejection in man.
The impact ofIFN administration on class II antigen expression byrat vascular
endothelial cells was directed in particular to the capillary endothelium, and is
most likely a direct one. In contrast, the antagonistic effect of MP may be
indirect, as we have not been able to downregulate la antigen expression of
endothelial cells by MP in vitro (our unpublished results).
The mechanism of regulation of tissue DC number is less clear. First, it is
possible that some dormant DC, which do not display class II at a given time,
exist in the tissue. This possibility is unlikely, as it goes against the definition of
a DC lineage (21). The second possibility is that the new cells are derived from
a pool ofrecirculating DC. This may be the case if IFN-y has a direct effect on
the permeability of the vascular wall and thus opens a gate through the vascular
endothelial barrier. This interpretation is also compatible with the inhibitory
effect of steroids. Unfortunately, the experimental conditions we used cannot
distinguish between these two alterations. In our view, it is unlikely that these
cells are newly synthesized DC from IFN-stimulated bone marrow, as it has been1476
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shown previously (22, 23) that it takes 7-10 d for such cells to reach the tissue
after bone marrow transplantation .
Two additional effects of IFN-y administration, both of which were inhibited
by steroids, were observed in this study. In the central vein area of liver,
administration of IFN-y was accompanied by a decrease in the number of la-,
ink' cells, and a concomitant increase in the number of la', ink` cells, whereas
in the portal area there was a decrease in number of la', ink' cells (no la-, ink`
cells are normally present in this location) . The effect in the central vein area is
likely to be explained by IFN-induced activation of mononuclear phagocytes,
which is inhibited by steroids . We have, at present, no explanation for the latter
phenomenon.
Summary
A single injection of 105 U/kg of recombinant rat IFN-y increases the amount
of tissue dendritic cells up to sixfold, and concomitantly induces the (capillary)
endothelial cells to express class 11 MHC antigens. Both responses peak on the
third day after IFN-y injection, and the antigen expression returns to basic levels
on day 7. Simultaneous administration of I mg/kg/d of methylprednisolone
entirely abolishes both responses. These observations demonstrate, for the first
time, that IFN-y and steroids have antagonistic effects on class II MHC antigen
presentation in tissue, and suggest that one immunosuppressive mechanism of
glucocorticosteroids in organ transplantation is downregulation of graft antigen-
icity.
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